From: The modified pancreatic stent system for prevention of post-ERCP pancreatitis: a case-control study
 | Ordinary group | New group | P |
---|---|---|---|
Placement time (min) | 3.5 ± 0.6 | 4.9 ± 0.7 | 0.000 |
 Hemodlastase (U/L) | |||
  Preoperative | 85.4 ± 48.9 | 81.9 ± 41.2 | 0.591 |
  Postoperative | 251.2 ± 348.7 | 235.2 ± 184.9 | 0.704 |
  pancreatic stent extubation | 81.8 ± 42.1 | 79.3 ± 25.8 | 0.622 |
 Serum lipase (U/L) | |||
  Preoperative | 172.8 ± 216.2 | 222.1 ± 175.7 | 0.081 |
  Postoperative | 620.8 ± 871.5 | 643.5 ± 737.4 | 0.843 |
  pancreatic stent extubation | 203.3 ± 192.9 | 214.7 ± 161.5 | 0.652 |